Here are 5 stocks that are buys right here, right now

Here are 5 stocks that are buys right here, right now


CNBC Investing Club with Jim Cramer

Rob Kim | NBCUniversal

Let’s say you just joined the Club, and you are trying to figure out which stocks we think are buyable right now, right here. Ideally, what I would like members to be thinking about is a companion portfolio of up to a dozen stocks to a market index fund position — something we recommend for investors just starting to manage their own money. Your own portfolio. Curated by us. Selected by you. More than 12 names, unless you’re a stock junkie like me, might be too hard to stay on top. Remember, buy and homework is my motto, not buy and hold and forget about it.

The question is: Which stocks would I buy right now? There are some in our 33-company portfolio that are just too high to recommend — and some, because of changes in circumstances are just too low, correctly low, and going lower like Salesforce after Wednesday evening’s quarter. We have a tough market. But I see stocks that are calling to me and saying it’s a good level to start. Not a single stock should be bought all at once. That’s a fool’s errand in a market that has developed a downward bias as we wrap up the month.



Source

Healthy Returns: AstraZeneca CEO proposes some U.S. drug price cuts amid Trump pressure
Health

Healthy Returns: AstraZeneca CEO proposes some U.S. drug price cuts amid Trump pressure

The office building of international biopharmaceutical company AstraZeneca. Cfoto | Future Publishing | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. President Donald Trump has been pressuring pharmaceutical companies to lower U.S. drug […]

Read More
Trump’s pharmaceutical tariffs could affect some drugmakers more than others
Health

Trump’s pharmaceutical tariffs could affect some drugmakers more than others

Medications are stored on shelves at a pharmacy on May 12, 2025 in Los Angeles, California. Eric Thayer | Getty Images President Donald Trump is slated to impose tariffs on pharmaceuticals imported into the U.S. any day now – and the duties may have a bigger impact on some drugmakers than others, according to some […]

Read More
Merck plans  billion cost cuts by end of 2027, narrows full-year outlook
Health

Merck plans $3 billion cost cuts by end of 2027, narrows full-year outlook

Merck & Co. signage on the floor of the New York Stock Exchange (NYSE) in New York, US, on Tuesday, April 8, 2025. Michael Nagle | Bloomberg | Getty Images Merck on Tuesday said it will slash $3 billion in costs by the end of 2027 to be fully reinvested to support new product launches […]

Read More